Sapala Organics

Hyderabad, India Founded: 2005 • Age: 21 yrs Acquired By Suven Pharmaceuticals
Research organization specializing in custom synthesis of various organic compounds

About Sapala Organics

Sapala Organics is a Healthcare company based in Hyderabad (India) founded in 2005, and was acquired by Suven Pharmaceuticals in June 2024. Research organization specializing in custom synthesis of various organic compounds. Sapala Organics has raised $734.96 thousand across 1 funding round from investors including Ventureast, Suven Pharma and Apidc. The company has 198 employees. Sapala Organics was last valued at $743.21 thousand in March 2007. Its Indian entity Sapala Organics Private Limited reported revenue of β‚Ή75.59 Cr. Sapala Organics offers products and services including Nucleoside and Phosphoramidites Derivatives, Linkers and Spacers, PEG Derivatives, and Miscellaneous Products. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and Medicinal Chemistry. Its competitors include Sai Life Sciences and NFIL; 1 of its 2 listed competitors has raised funding.

Company details

Sapala Organics was established in 2005 as a contract research organization focused on organic synthesis within life and material sciences sectors. Services encompass custom synthesis of diverse organic compounds, supported by analytical method development. The organization operates from Hyderabad, India, and is equipped with modern facilities for synthesis and analysis to meet research needs.

Key Metrics
  • Annual Revenue
    ₹75.59 Cr

    FY 2024 · -14% YoY

  • EBITDA
    ₹31.64 Cr

    FY 2024 · 42% margin

  • Total Equity Funding
    $734.96K (USD)

    in 1 rounds

  • Latest Funding Round
    $734.96K (USD), Seed

    Mar 2007

  • Investors
    Ventureast

    & 2 more

  • Employee Count
    198
  • Acquired by

Products & Services of Sapala Organics

Sapala Organics offers a comprehensive portfolio of products and services, including Nucleoside and Phosphoramidites Derivatives, Linkers and Spacers, PEG Derivatives, and Miscellaneous Products.

Nucleoside and Phosphoramidites Derivatives
Chemical Products

Specialized building blocks for oligonucleotide synthesis and drug development.

Linkers and Spacers
Chemical Products

Compounds for drug delivery and molecular connections in therapies.

PEG Derivatives
Chemical Products

Used for enhancing solubility in nucleic acid-based treatments.

Miscellaneous Products
Chemical Products

Various compounds supporting research in medicinal chemistry.

Funding Insights of Sapala Organics

Sapala Organics has successfully raised a total of $734.96K through 1 strategic funding round. The most recent funding activity was a Seed round of $734.96 thousand completed in March 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $734,962
  • Total Rounds 1
  • Last Round Seed β€” $734,962
  • First Round $734,962

    (Mar 2007)

  • Investors Count 2

All 1 funding rounds of Sapala Organics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2007$734,962Seed$743,207Ventureast
Valuation history

Last known valuation $743,207 (Mar 2007). 3 investors in total: 3 institutional.

Investors in Sapala Organics

Sapala Organics has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Ventureast, Suven Pharma and Apidc.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital investments in technology, healthcare, and clean environment sectors since 1997.
1997ventureast.netBengaluru, India
apidc.gov.in
Contract manufacturing and development of APIs and formulations are provided.
1989suvenpharm.comHyderabad, India
Premium access

Investor details for Sapala Organics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Sapala Organics Private Limited (Sapala Organics)

Sapala Organics Private Limited is the primary company behind Sapala Organics. The board of Sapala Organics Private Limited currently have 5 directors; the longest-serving is Paidi Reddy Yella, appointed in 2017. 23 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Paidi Reddy Yella
DIN 01995305
Director05 May 20179 yrs 6 moSapala Organics Private Limited
Sai Krishna Reddy Paidi
DIN 08807747
Director24 Jul 20206 yrs 3 moSapala Organics Private Limited
Atin Hirachand Jain
DIN 08948630
Director12 Jul 20242 yrs 4 moSapala Organics Private Limited
Himanshu Agarwal
DIN 06672915
Director12 Jul 20242 yrs 4 moSapala Organics Private Limited
Kumarapuram Gopalakrishnan Ananthakrishnan
DIN 00019325
Director31 Jul 20242 yrs 3 moSapala Organics Private Limited

People of Sapala Organics

2 people are tracked at Sapala Organics (2 in leadership); the tracked headcount is 198.

NameRoleGroup
Ashok Jha
Head Of Tech OpsLeadership
Paidi Reddy Ph.D
Co-Founder, Scientific Advisory Board Member, President, Co-Chief Executive Officer, Managing DirectorLeadership
Premium access

Complete people profiles for Sapala Organics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Sapala Organics

Figures of Sapala Organics Private Limited, the primary company behind Sapala Organics, for FY 2024. Revenue was ₹75.59 Cr (-14% year on year). EBITDA was ₹31.64 Cr (42% margin). Revenue has grown at a compounded annual rate of +20% over three years and +20% over five years.

  • ₹75.59 CrRevenue · FY 2024 · -14% YoY
  • ₹31.64 CrEBITDA · 42% margin
  • ₹8.64 CrPaid-up capital
  • 198Employees (provident fund records)
  • +20%Revenue CAGR, 3 years
  • +20%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Sapala Organics Private Limited are on its company page.

Premium access

Detailed financial statements for Sapala Organics

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Sapala Organics

3 dated milestones of Sapala Organics across 19 years, from founding to its latest funding, stage changes and deals.

  1. Founded Sapala Organics is founded.
  2. Funding First funding round of $735K.
  3. Exit Acquired by Suven Pharmaceuticals.

Competitors of Sapala Organics

Sapala Organics has 2 listed competitors in our database, 1 of them funded. They include Sai Life Sciences and NFIL.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
sailife.com1999Hyderabad, India$112.18M2,948
Complex small molecules are discovered, developed, and manufactured for pharmaceuticals.
nfil.in1967Mumbai, India1,476
Fluorinated compounds are synthesized and manufactured customly for various industries.
Premium access

Detailed competitors of Sapala Organics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Sapala Organics (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M2,062
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M548
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M557
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Sapala Organics

Premium access

Complete news archive for Sapala Organics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sapala Organics

Sapala Organics was founded in 2005 and raised its 1st funding round 2 years after it was founded.

Sapala Organics is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Sapala Organics is a funded company, having raised a total of $734.96K across 1 funding round to date. The company's 1st funding round was a Seed of $734.96K, raised on Mar 2007.

Sapala Organics has 198 employees.

The primary company behind Sapala Organics, Sapala Organics Private Limited, reported revenue of β‚Ή75.59 Cr for FY 2024, down 14% year on year.

Sapala Organics was established in 2005 as a contract research organization focused on organic synthesis within life and material sciences sectors. Services encompass custom synthesis of diverse organic compounds, supported by analytical method development. The organization operates from Hyderabad, India, and is equipped with modern facilities for synthesis and analysis to meet research needs.

Sapala Organics's top competitors include Sai Life Sciences and NFIL.

Sapala Organics offers Nucleoside and Phosphoramidites Derivatives, Linkers and Spacers, PEG Derivatives, and Miscellaneous Products.

Sapala Organics has 3 investors. Key investors include Ventureast, Suven Pharma, and Apidc.

The valuation of Sapala Organics is $743.21K as of Mar 2007.

Sapala Organics operates through Sapala Organics Private Limited.

Yes. Sapala Organics was acquired by Suven Pharmaceuticals in June 2024.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available